LifeScan announced that its Chapter 11 bankruptcy reorganization plan received U.S. Bankruptcy Court approval.
Dexcom faces new FDA reports linking its G7 glucose monitor to patient deaths as lawsuits and regulatory scrutiny intensify.
Opinion - In South Africa, two people can live with the same chronic condition yet face vastly different realities.
The United States Insulin Pump Market is projected to grow from US$ 1.55 billion in 2024 to US$ 2.58 billion in 2033, with a ...
The Special Meeting of Shareholders held on October 31, 2025 Shareholders vote on Equity Purchase Agreement with Sixth Borough Capital Fund RUTHERFORD, N.J., Oct. 28, 2025 (GLOBE NEWSWIRE) -- ...
Lifecare ASA has received confirmation from the Norwegian Medical Products Agency (NOMA) that its application for a first-in-human clinical study of its continuous glucose monitoring system is ...